Diversified Healthcare Trust (DHC) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings report shows strong financial performance, with key metrics exceeding expectations, such as Normalized FFO and Adjusted EBITDAre. The company is experiencing NOI growth across segments and improving margins, which are positive indicators. The Q&A section provides additional insights into strategic investments and cost management, with management reaffirming guidance despite some uncertainties. The focus on ROI and reduced leverage adds to the positive sentiment. Overall, the financial health and strategic direction suggest a positive stock price movement.
Key Financial Performance
Normalized FFO $33.1 million or $0.14 per share, ahead of analyst consensus estimate.
Adjusted EBITDAre $74 million, ahead of analyst consensus estimate.
Consolidated NOI $75.9 million, a 4.7% increase year-over-year.
Same-property SHOP NOI $44.3 million, a 13.5% increase year-over-year, driven by 110 basis points occupancy growth and 5.9% average monthly rate growth.
Same-property NOI margin Expanded by 160 basis points to 14.9%, with occupancy holding at 82.4%. Margin improvement driven by revenue growth (4.5% average annual rate increase) and cost efficiencies (new dietary contracts, reduced labor costs).
Medical Office and Life Science portfolio NOI $25.4 million, a 3.7% increase year-over-year and a 4.8% increase sequentially. Same-property occupancy increased 60 basis points year-over-year to 95.3%.
Same-property cash basis NOI $75.9 million, an 8.6% increase year-over-year and a 7.8% increase sequentially.
SHOP same-property NOI (adjusted for insurance proceeds) Would have increased 22% year-over-year.
Same-property average monthly rate Increased 590 basis points year-over-year and 320 basis points sequentially.
Contract labor costs Decreased nearly 35% year-over-year.
Net debt to annualized adjusted EBITDAre 7.8x at quarter end, down from 8.8x a year ago, driven by improved operating performance.
Adjusted EBITDAre to interest expense Improved to 2x from 1.3x a year ago.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Senior Housing Market: DHC is capitalizing on the growing demand from an aging population and a historically low new supply pipeline for senior housing. They are repositioning underutilized or closed skilled nursing wings into independent living, assisted living, or memory care units. Six initial projects costing approximately $20 million will add 150 units, expected to yield mid-teen returns.
Medical Office and Life Science Portfolio: Same-property occupancy increased to 95.3%, generating $25.4 million in NOI, a 3.7% year-over-year increase. Leasing activity included 169,000 square feet of new and renewal leases at rents 12% above prior levels.
Operational Efficiencies in SHOP Portfolio: Same-property NOI increased 13.5% year-over-year, driven by occupancy growth and rate increases. New dietary and food contracts reduced costs while enhancing resident experience. Labor costs moderated with reduced contract labor and optimized staffing.
Capital Recycling Program: DHC completed a large-scale capital recycling program, transitioning from portfolio transformation to value creation. Proceeds from asset sales and reinvestments are expected to generate low to mid-teen returns.
Debt and Balance Sheet Management: Net debt to annualized adjusted EBITDAre improved to 7.8x from 8.8x a year ago. Moody's upgraded DHC's corporate family rating to B3 with a positive outlook. No debt maturities until 2028, providing operational focus.
Capital Deployment Strategy: DHC is selectively deploying capital into high-return projects, such as converting underutilized spaces into senior housing units. These projects are expected to be immediately accretive to earnings upon completion.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Medical Office and Life Science Portfolio Lease Expirations: Approximately 9% of annualized rental income is scheduled to expire through 2026, with 4.9% expected to vacate. This could impact revenue stability and occupancy rates.
Capital Allocation and ROI Projects: The company plans to invest $20 million in repositioning projects, which, while potentially accretive, carry risks related to execution, cost overruns, and market acceptance of the new units.
Debt Leverage: Net debt to annualized adjusted EBITDAre is 7.8x, which, while improved, remains relatively high and could pose risks if operating performance does not meet expectations.
Labor Costs and Contract Labor: Although labor costs have moderated, any reversal in this trend or challenges in maintaining reduced contract labor could increase operational expenses.
Economic and Market Conditions: The company’s performance is tied to favorable demographic trends and limited new supply growth in senior housing. Any adverse changes in these conditions could impact growth.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Senior Housing Operating Portfolio (SHOP) Outlook: DHC expects to capitalize on increasing demand from an aging population and limited new supply in senior housing. The company plans to selectively deploy capital into high-return ROI projects, including converting underutilized skilled nursing wings into independent living, assisted living, or memory care units. The first phase involves six projects costing approximately $20 million, expected to add 150 units and generate mid-teen returns upon completion.
Medical Office and Life Science Portfolio Outlook: DHC anticipates stable performance with 9% of annualized rental income scheduled to expire through 2026. The company has already signed leases totaling 390,000 square feet, addressing 29% of 2027 expirations. Leasing activity is expected to remain healthy, with rents 12% above prior levels and a weighted average lease term of 9.5 years.
Capital Expenditures Guidance: DHC reaffirms its 2026 recurring capital expenditure guidance of $100 million to $115 million, representing an 18% reduction at the midpoint compared to prior levels.
Debt and Liquidity Outlook: DHC aims to reach a near-term leverage target range of 6.5x to 7.5x, primarily driven by growth in SHOP NOI. The company has no debt maturities until 2028 and maintains a strong liquidity position with $272 million in total liquidity.
Full-Year 2026 Financial Guidance: DHC reaffirms its full-year 2026 guidance, including $175 million to $185 million of SHOP NOI, $94 million to $98 million of Medical Office and Life Science NOI, $28 million to $30 million of NOI from triple net lease senior living communities and wellness centers, adjusted EBITDAre of $290 million to $305 million, and normalized FFO of $0.52 to $0.58 per share.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the recurring CapEx expectations for the seniors housing operating portfolio?
A:The recurring CapEx is expected to be $80 million to $90 million, which includes maintenance capital and some refresh capital. Maintenance capital costs are expected to modestly decrease over time, while redevelopment capital will remain firm for 2026 and increase in 2027 depending on ROI projects.
Q:Will the recurring CapEx number of $3,500 per unit decrease in the future?
A:Yes, the $3,500 per unit is expected to decrease in future periods. For 2026, this number excludes $5 million to $10 million of refresh capital embedded within the recurring CapEx.
Q:Are new investment opportunities focused on wing expansions or acquisitions?
A:New investment opportunities are mostly focused on renovations and improving existing communities, with an emphasis on expanding acuity within the communities before considering acquisitions.
Q:How does the stock performance affect the base management fee within the G&A guidance?
A:The base management fee fluctuates with the share price, which introduces volatility to the G&A guidance. However, the overall guidance range remains accurate and may trend higher due to SHOP NOI exceeding expectations.
Q:Are there any one-time items impacting 1Q '25 comps or financial reports for 1Q '26?
A:The most material one-time item is the $2.7 million of business interruption insurance proceeds received in Q1 '25. There is some minor noise, but nothing significant.
Q:What is the status of the Aleris property transitions and their impact on 1Q '26 results?
A:The Aleris property transitions are going well, with operators revisiting employment structures and sales teams. Costs associated with the transition are captured in transaction-related costs, and incremental benefits are expected through 2026.
Q:Why was same-property occupancy flat quarter-over-quarter in the SHOP space?
A:The flat occupancy reflects both seasonality and friction from operator transitions. Despite disruptions, holding occupancy during this period is seen as a positive sign for future performance.
Q:How is 2Q SHOP performance trending so far?
A:Specific numbers for 2Q are not yet available, but the company reaffirms its guidance and expects further improvement.
Q:What factors contribute to the difference in SHOP NOI growth implied in guidance versus 1Q performance?
A:The difference is due to higher comps in 1Q '25, expected 300 basis point year-over-year occupancy growth, 5+% rate growth, and seasonal expenses affecting quarterly run rates.
Q:What is the expected impact of previous CapEx spend on 2026 and 2027 NOI?
A:Renovations from 2023 and 2024 are starting to stabilize and show meaningful results. Refreshes from 2025 will contribute to NOI in late 2026 and 2027, with a typical stabilization period of 18 to 20 months.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on 2Q SHOP performance, citing that April numbers were still coming in. They also used vague language when discussing incremental benefits from operator transitions and the potential for further improvement in guidance.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Consolidated NOI
Demand fundamental
EBITDAre analyst
ETF GA
GA expense
Leasing activity
Medical Office
NOI increase
NOI insurance
NOI operator
NOI property
Office Life
REITs measurement
Relations Today
SHOP property
SP gain
Science portfolio
class operator
contract labor
cost
focus
foot renewal
housing
living
margin improvement
partner
portfolio result
price
program
project
property NOI
purchase
repositioning
supply
wing
DHC Transcript
Diversified Healthcare Trust (DHC) Q1 2026 Earnings Call Transcript
Positive5-5
The earnings report shows strong financial performance, with key metrics exceeding expectations, such as Normalized FFO and Adjusted EBITDAre. The company is experiencing NOI growth across segments and improving margins, which are positive indicators. The Q&A section provides additional insights into strategic investments and cost management, with management reaffirming guidance despite some uncertainties. The focus on ROI and reduced leverage adds to the positive sentiment. Overall, the financial health and strategic direction suggest a positive stock price movement.
Diversified Healthcare Trust (DHC) Q4 2025 Earnings Call Transcript
Positive2-24
The earnings call reflects positive financial performance with significant improvements in NOI margins and leverage reduction. The strategic focus on operational performance and disciplined capital spending is promising. While the Q&A revealed some uncertainties, such as unclear timelines for reopening wings and acquisition strategies, the overall outlook remains optimistic. The positive elements, including strong occupancy and pricing momentum, outweigh the minor concerns, supporting a positive sentiment.
Diversified Healthcare Trust (DHC) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call highlights positive financial performance with increased revenues, NOI, and occupancy across various segments. Despite temporary labor cost increases, the company maintains strong guidance and expects favorable transitions. The Q&A section reveals management's confidence in achieving targets and mitigating risks. The increase in SHOP NOI guidance and active disposition pipeline further support a positive outlook. However, the lack of specific details on potential revenue disruptions and disposition delays warrants caution. Overall, the sentiment leans towards positive due to strong financial metrics and optimistic guidance.
Diversified Healthcare Trust (DHC) Q2 2025 Earnings Call Transcript
Positive8-5
The earnings call highlights strong financial performance with a 3% revenue increase and a significant 172% FFO growth, driven by operational improvements. Despite high interest rates on new financing, the company's asset sales and debt management strategies are positive. The Q&A reveals strategic asset dispositions and gradual occupancy growth, with no major negative trends. The reaffirmed guidance and improved debt metrics indicate stability. Overall, the sentiment is positive, suggesting a potential stock price increase of 2% to 8% over the next two weeks.
DHC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
